2018
DOI: 10.1016/j.ajg.2018.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound, endoscopic ultrasound elastography, and the strain ratio in differentiating benign from malignant lymph nodes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 27 publications
0
10
0
Order By: Relevance
“…They examined 126 LNs, with a SR cut-off value of 4.6 for malignant LNs. The specificity, sensitivity, NPV, and PPV were 83.3%, 89.8%, 90.2%, and 82.5%, respectively [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…They examined 126 LNs, with a SR cut-off value of 4.6 for malignant LNs. The specificity, sensitivity, NPV, and PPV were 83.3%, 89.8%, 90.2%, and 82.5%, respectively [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…This was comparable to the study done by Paterson et al [ 12 ] that identified a cut-off level of 7.5 that had specificity and PPV of 96% and 95%, respectively, but higher values of sensitivity, NPV, and accuracy of 83%, 86%, and 90%, respectively. Okasha et al [ 11 ] and Larsen et al [ 13 ] identified a lower cut-off value for SR of 4.6 and 4.5 that gave lower values in specificity and PPV of 83.3%, 82.5% and 82%, 67%, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…26 In another prospective study comprising 126 patients with lymphadenopathy, the sensitivity and specificity of EUS-guided detection of malignant lymph nodes were 89.8% and 83.3%, respectively. 27 Percutaneous ultrasound-guided portal FNA is currently seldom used because of its invasiveness and a relative high risk of complications. In 2004, Lai et al 29 reported the first case of HCC diagnosis using EUS-FNA of portal vein thrombus, the initial CT scan displayed a thrombosis in the portal vein, intrahepatic biliary dilatation, and a suspicious soft-tissue mass in the pancreatic head.…”
Section: Eus For the Diagnosis Of Metastatic Lymph Nodesmentioning
confidence: 99%
“…When judging malignant LNs with SR, previous research showed that with the cutoff point of SR >2.5, EUS elastography can differentiate benign from atypical malignant mediastinal LN sensitively (56). Okasha et al reported that there were 89.8% sensitivity and 83.3% specificity in differentiating malignant LNs from benign ones with endoscopic UE while using the SR cutoff value >4.61 (55). Altonbary et al found that the sensitivity, specificity, PPV, NPV, and diagnostic accuracy for differentiating benign LNs from malignant LNs were 57.1%, 99.9%, 99.9%, 64%, and 77.5%, respectively, with the mean SR cutoff value >6.7 (53).…”
Section: Differentiation Of Benign and Malignant Lymph Nodesmentioning
confidence: 99%